Discover 1,147 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,147
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
for
Ovarian Cancer Recurrent
Location: New Haven CT, New York NY, Boston MA, Montreal,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06843447
Phase1, Phase2, Recruiting
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
for
Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer
Location: New Haven CT
Sponsor: Yale University
Sex: Female
Age: 18+
Code: NCT05989347
Phase1, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: New Haven CT, Mineola NY, New York NY, Brooklyn NY,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase1, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: New Haven CT, Stony Brook NY, Lake Success NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase1, Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,
Location: New Haven CT, North Haven CT, Derby CT, Guilford CT,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT05806515
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: New Haven CT, New Britain CT, Danbury CT, Norwalk CT,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: New Haven CT, New York NY, Hackensack NJ, Boston MA,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase1, Recruiting
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
for
Metastatic Small Intestinal Adenocarcinoma,
Location: New Haven CT, Orange CT, North Haven CT, Derby CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04205968
Phase2, Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
for
Refractory Differentiated Thyroid Gland Carcinoma
Location: New Haven CT, North Haven CT, Derby CT, Guilford CT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06475989
Phase3, Recruiting
New
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
for
Advanced Pancreatic Ductal Adenocarcinoma,
Location: New Haven CT
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07619521
Phase1, Phase2, Recruiting
New
Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial
for
Clear Cell Renal Cell Carcinoma,
Location: New Haven CT
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07516366
Phase2, Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Philadelphia PA, Detroit MI,
Sponsor: Fate Therapeutics
Sex: All
Age: 18+
Code: NCT06241456
Phase1, Recruiting
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
for
Squamous Non-small-cell Lung Cancer,
Location: New Haven CT, Hackensack NJ, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT06747585
Phase1, Phase2, Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: New Haven CT, Lake Success NY, New York NY, Boston MA,
Sponsor: Synthekine
Sex: All
Age: 18+
Code: NCT05098132
Phase1, Phase2, Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors